Symptom trajectories during chemotherapy in patients with non‐small cell lung cancer ( NSCLC ) and the function of prolonging low dose dexamethasone in promoting enhanced recovery after chemotherapy-Reference-Cited by-同舟云学术

Symptom trajectories during chemotherapy in patients with non‐small cell lung cancer ( NSCLC ) and the function of prolonging low dose dexamethasone in promoting enhanced recovery after chemotherapy

Published:2021-01-25 Issue:6 Volume:12 Page:783-795
ISSN:1759-7706
Container-title:Thoracic Cancer
language:en
Short-container-title:Thoracic Cancer

Author:

Liu Jinghao¹,Liu Xingyu¹^ORCID,Dong Ming¹,Zhao Honglin¹,Li Mei¹,Zhang Hongbing¹,Ji Huihui¹,Shi Yi¹,Cui Yajie¹,Wu Di¹,Chen Gang¹,Chen Jun¹²

Affiliation:

1. Department of Lung Cancer Surgery, Tianjin key laboratory of lung cancer metastasis and tumor microenvironment Tianjin Lung Cancer Institute, Tianjin Medical University General Hospital Tianjin China

2. Department of Thoracic Surgery, First Affiliated Hospital School of Medicine, Shihezi University Shihezi China

Funder

National Natural Science Foundation of China

Natural Science Foundation of Tianjin City

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1759-7714.13830

Reference30 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries